• head_banner_01

Izindaba zemboni

  • Ukwephula I-Bottleneck Ekukhuluphaleni Nokwelashwa Kwesifo Sikashukela: Ukusebenza Okumangalisayo Kwe-Tirzepatide.

    Ukwephula I-Bottleneck Ekukhuluphaleni Nokwelashwa Kwesifo Sikashukela: Ukusebenza Okumangalisayo Kwe-Tirzepatide.

    I-Tirzepatide iyinoveli ekabili ye-GIP/GLP-1 receptor agonist ebonise isithembiso esihle ekwelapheni izifo ze-metabolic. Ngokulingisa izenzo zamahomoni amabili emvelo e-incretin, athuthukisa ukukhiqizwa kwe-insulin, acindezele amazinga eglucagon, futhi anciphise ukudla okudlayo—okusiza ngokuphumelelayo ukulawula ...
    Funda kabanzi
  • Yehlisa Ingozi Yokwehluleka Kwenhliziyo ngama-38%! I-Tirzepatide Ilungisa Kabusha Indawo Yokwelashwa Kwenhliziyo

    Yehlisa Ingozi Yokwehluleka Kwenhliziyo ngama-38%! I-Tirzepatide Ilungisa Kabusha Indawo Yokwelashwa Kwenhliziyo

    I-Tirzepatide, i-novel dual receptor agonist (GLP-1/GIP), izuze ukunakwa okukhulu eminyakeni yamuva nje ngeqhaza layo ekwelapheni isifo sikashukela. Nokho, amandla ayo ezifweni zenhliziyo nemithambo yegazi nezinso ayavela kancane kancane. Ucwaningo lwakamuva lukhombisa ukuthi i-tirzepatide ...
    Funda kabanzi
  • I-Oral Semaglutide: I-Needle-Free Breakthrough in Diabetes and Weight Management

    I-Oral Semaglutide: I-Needle-Free Breakthrough in Diabetes and Weight Management

    Esikhathini esidlule, i-semaglutide yayitholakala ngokuyinhloko efomini elijovayo, elivimbela ezinye iziguli ezazizwela izinaliti noma zesaba ubuhlungu. Manje, ukwethulwa kwamaphilisi omlomo kuwushintshile umdlalo, okwenza imithi ibe lula. Lawa maphilisi omlomo we-semaglutide asebenzisa i-formulatio ekhethekile...
    Funda kabanzi
  • I-Retatrutide iguqula indlela okuphathwa ngayo ukukhuluphala

    I-Retatrutide iguqula indlela okuphathwa ngayo ukukhuluphala

    Emphakathini wanamuhla, ukukhuluphala sekuphenduke inselele yezempilo emhlabeni wonke, futhi ukuvela kwe-Retatrutide kunikeza ithemba elisha ezigulini ezinenkinga yesisindo esiningi. I-Retatrutide iyi-agonist yama-receptor amathathu eqondise ku-GLP-1R, GIPR, kanye ne-GCGR. Lo mbukiso oyingqayizivele we-multi-target synergistic mechanism demonstrat...
    Funda kabanzi
  • Ukusuka Kushukela Wegazi Kuya Esisindo Somzimba: Kwembula Ukuthi I-Tirzepatide Ilungisa Kabusha Indlela Yokwelapha Yezifo Eziningi

    Ukusuka Kushukela Wegazi Kuya Esisindo Somzimba: Kwembula Ukuthi I-Tirzepatide Ilungisa Kabusha Indlela Yokwelapha Yezifo Eziningi

    Esikhathini sokuthuthuka okusheshayo kwezokwelapha, i-Tirzepatide iletha ithemba elisha ezigulini ezinezifo ezingelapheki ezihlukahlukene ngokusebenzisa indlela yayo yokusebenza ehlosiwe eminingi. Lokhu kwelashwa okusha kweqa imikhawulo yokwelashwa kwendabuko futhi kunikeza isixazululo esiphephile, esihlala isikhathi eside ...
    Funda kabanzi
  • Izinzuzo Zezempilo Zemithi ye-GLP-1

    Izinzuzo Zezempilo Zemithi ye-GLP-1

    Eminyakeni yamuva nje, ama-GLP-1 receptor agonists (GLP-1 RAs) aqhamuke njengomdlali obalulekile ekwelapheni isifo sikashukela nokukhuluphala, abe yingxenye ebalulekile yokulawulwa kwezifo ze-metabolic. Le mithi ayidlali indima ebalulekile nje kuphela ekulawulweni kukashukela egazini kodwa futhi ikhombisa imiphumela emangalisayo esisindo...
    Funda kabanzi
  • I-Semaglutide VS Tirzepatide

    I-Semaglutide VS Tirzepatide

    I-Semaglutide ne-Tirzepatide imithi emibili emisha esekwe ku-GLP-1 esetshenziselwa ukwelapha uhlobo lwesifo sikashukela sohlobo lwe-2 nokukhuluphala. I-Semaglutide ibonise imiphumela ephakeme ekunciphiseni amazinga e-HbA1c nokukhuthaza ukulahlekelwa isisindo. I-Tirzepatide, inoveli ekabili ye-GIP/GLP-1 receptor agonist, nayo ivunywe ...
    Funda kabanzi
  • Iyini i-Orforglipron?

    Iyini i-Orforglipron?

    I-Orforglipron iyinoveli yohlobo lwesifo sikashukela sohlobo 2 kanye nomuthi wokwelashwa wokuncipha kwesisindo esakhiwayo futhi kulindeleke ukuthi ibe ngenye indlela yomlomo kunemithi ejovwayo. Ingowomndeni wama-agonist we-glucagon-like peptide-1 (GLP-1) futhi ifana ne-Wegovy evame ukusetshenziswa (Semaglutide) kanye ne-Mounja...
    Funda kabanzi
  • Uyini umehluko phakathi kwempahla eluhlaza ye-semaglutide ene-99% ubumsulwa nokuthi nge-98% ubumsulwa?

    Uyini umehluko phakathi kwempahla eluhlaza ye-semaglutide ene-99% ubumsulwa nokuthi nge-98% ubumsulwa?

    Ukuhlanzeka kwe-Semaglutide kubalulekile kukho konke ukusebenza kahle nokuphepha kwayo. Umehluko omkhulu phakathi kwe-Semaglutide API ene-99% ubumsulwa kanye ne-98% ubumsulwa butholakala kumthamo wesithako esisebenzayo esikhona kanye nezinga elingaba khona lokungcola entweni. Lapho ubumsulwa buphezulu, bukhulu isilinganiso...
    Funda kabanzi
  • Yini okufanele ngiyenze uma ngingehli isisindo ngemuva kokusebenzisa izidakamizwa ze-GLP-1?

    Yini okufanele ngiyenze uma ngingehli isisindo ngemuva kokusebenzisa izidakamizwa ze-GLP-1?

    Yini okufanele uyenze uma ungehli isisindo emuthini we-GLP-1? Okubalulekile, ukubekezela kubalulekile lapho uthatha umuthi we-GLP-1 njenge-semaglutide. Ngokufanelekile, kuthatha okungenani amaviki ayi-12 ukubona imiphumela. Nokho, uma ungaboni ukwehla kwesisindo ngaleso sikhathi noma unokukhathazeka, nazi ezinye izinketho ongazicabangela. Tal...
    Funda kabanzi
  • I-Tirzepatide: Umnakekeli wezempilo yenhliziyo

    I-Tirzepatide: Umnakekeli wezempilo yenhliziyo

    Isifo senhliziyo singenye yezinsongo ezihamba phambili zezempilo emhlabeni wonke, futhi ukuvela kwe-Tirzepatide kuletha ithemba elisha lokuvimbela nokwelashwa kwezimo zenhliziyo. Lo muthi usebenza ngokwenza kokubili i-GIP kanye ne-GLP-1 receptors, hhayi nje ukuqhubeka ngempumelelo...
    Funda kabanzi
  • Umjovo we-insulin

    I-insulin, eyaziwa ngokuthi “umjovo kashukela”, ikhona emzimbeni wawo wonke umuntu. Abanesifo sikashukela abanayo i-insulin eyanele futhi badinga i-insulin eyengeziwe, ngakho badinga ukuthola imijovo. Nakuba kuwuhlobo lomuthi, uma ujovwe ngendlela efanele nangesilinganiso esifanele, “...
    Funda kabanzi